123 related articles for article (PubMed ID: 1830934)
21. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
Nishiyama T; Yokoyama T; Yamashita K
J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
[TBL] [Abstract][Full Text] [Related]
22. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
23. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
Noda Y; Nakamura M; Sasaki M; Kosugi T
Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
[TBL] [Abstract][Full Text] [Related]
25. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
26. [Influence of thoracotomy and pulmonary surgery on coagulation and fibrinolysis in the intra and postoperative period--experimental and clinical study].
Sembo J
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):199-209. PubMed ID: 2747605
[TBL] [Abstract][Full Text] [Related]
27. Fibrinolysis-coagulation system in patients with cancer of the head and neck. Preliminary report.
Kosugi T; Takagi I; Ariga Y; Okada S; Morimitsu T; Mihara H
Arch Otorhinolaryngol; 1982; 236(3):211-5. PubMed ID: 7159273
[TBL] [Abstract][Full Text] [Related]
28. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
29. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
Homma T; Ichikawa T
Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
[TBL] [Abstract][Full Text] [Related]
30. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
31. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
32. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
33. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
34. Plasma alpha 2-plasmin inhibitor-plasmin complex and FDP-D-Dimer in fulminant hepatic failure.
Tomiya T; Hayashi S; Ogata I; Fujiwara K
Thromb Res; 1989 Feb; 53(3):253-60. PubMed ID: 2524118
[TBL] [Abstract][Full Text] [Related]
35. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
36. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of alpha 2-plasmin inhibitor].
Mimuro J; Aoki N
Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
[No Abstract] [Full Text] [Related]
38. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
Nakamichi S
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
[No Abstract] [Full Text] [Related]
39. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
[TBL] [Abstract][Full Text] [Related]
40. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
